| PERIOD ENDING | 31-Oct-09 | 1-Aug-09 | 2-May-09 | 31-Jan-09 | | Total Revenue | 4,179,000 | 3,943,000 | 3,884,000 | 5,759,000 | | Cost of Revenue | 2,483,000 | 2,423,000 | 2,310,000 | 3,764,000 | | | Gross Profit | 1,696,000 | 1,520,000 | 1,574,000 | 1,995,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,622,000 | 1,152,000 | 1,345,000 | 1,475,000 | | Non Recurring | (156,000) | 180,000 | 3,000 | 5,000 | | Others | 123,000 | 121,000 | 120,000 | 126,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 107,000 | 67,000 | 106,000 | 389,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| 43,000 | | Earnings Before Interest And Taxes | (88,000) | 67,000 | 106,000 | 432,000 | | Interest Expense | (131,000) | 68,000 | 63,000 | 104,000 | | Income Before Tax | 43,000 | (1,000) | 43,000 | 328,000 | | Income Tax Expense | 16,000 |
-
| 18,000 | 120,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 27,000 | (1,000) | 25,000 | 208,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| 3,000 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 27,000 | (1,000) | 25,000 | 211,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $27,000 | ($1,000) | $25,000 | $211,000 |
|
0.51% Nasdaq 
0.29 (1.06%) 
Income Statement
